{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:20:04Z","timestamp":1790630404384,"version":"4.1.0"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Macrophage polarization plays a critical role in shaping the immunosuppressive tumor microenvironment (TME) of prostate cancer (PCa). Tumor-associated macrophages (TAMs), particularly those exhibiting immunoregulatory and tumor-promoting transcriptional programs, contribute to disease progression, immune evasion, and therapeutic resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To comprehensively map the research landscape of macrophage polarization and activation in PCa using bibliometric tools and to assess translational progress through a review of clinical trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A bibliometric analysis was conducted using VOSviewer, CiteSpace, and R, based on publications related to macrophage polarization and activation in PCa. Additionally, eligible interventional clinical trials in prostate cancer were identified through predefined searches of ClinicalTrials.gov and PubMed, and 20 trials were included in the descriptive synthesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Bibliometric findings revealed growing research interest in macrophage polarization since 2015, with key themes including immune suppression, cytokine signaling, and therapeutic resistance. High-frequency keywords highlighted macrophage plasticity\/heterogeneity (often captured by M1\/M2-related terms in the literature), immune checkpoints, and TME reprogramming. Clinical trials investigated a range of strategies, including CSF1R inhibition (e.g., cabiralizumab, PLX3397), TAM reprogramming strategies, checkpoint blockade, and combination therapies with PARP inhibitors, radiotherapy, and vaccines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The integration of bibliometric insights with clinical trial and published data highlights the increasing translational focus on TAM\/TME-targeted therapies in PCa. These findings underscore macrophage polarization as a promising immunotherapeutic axis and emphasize the need for further clinical innovation and biomarker-driven strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1784198","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:25:00Z","timestamp":1777868700000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Mapping research trends in macrophage polarization and immunotherapeutic potential in prostate cancer: a bibliometric and visual analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Pengze","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine, North Sichuan Medical College","place":["Nanchong, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hospital of Chengdu University","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hospital of Chengdu University","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengwu","family":"He","sequence":"additional","affiliation":[{"name":"Department of Urology, The Eighth Affiliated Hospital, Sun Yat-sen University","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aifa","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of General Practice Medicine, Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group)","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group), Shenzhen University","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-024-01614-6","article-title":"Prostate cancer, pathophysiology and recent developments in management: a narrative review","volume":"26","author":"Almeeri","year":"2024","journal-title":"Curr Oncol Rep"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.0228","article-title":"Prostate cancer: a review","author":"Raychaudhuri","year":"2025","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100776","article-title":"Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy","volume":"8","author":"Fendl","year":"2023","journal-title":"ESMO Open"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006020","article-title":"YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6","volume":"11","author":"Chen","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1443366","article-title":"Chemokines in the tumor microenvironment: implications for lung cancer and immunotherapy","volume":"15","author":"Jung","year":"2024","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S441135","article-title":"TME-related biomimetic strategies against cancer","volume":"19","author":"Peng","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","article-title":"Microenvironment-driven metabolic adaptations guiding CD8(+) T cell anti-tumor immunity","volume":"56","author":"Park","year":"2023","journal-title":"Immunity"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012418-012718","article-title":"Diversity, mechanisms, and significance of macrophage plasticity","volume":"15","author":"Locati","year":"2020","journal-title":"Annu Rev Pathol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-023-01478-6","article-title":"Metabolism, metabolites, and macrophages in cancer","volume":"16","author":"Li","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087493","article-title":"Tumor-associated macrophage subsets: shaping polarization and targeting","volume":"24","author":"Zhang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2023.100928","article-title":"Gut microbiota-derived short-chain fatty acids promote prostate cancer progression via inducing cancer cell autophagy and M2 macrophage polarization","volume":"43","author":"Liu","year":"2023","journal-title":"Neoplasia"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-023-04854-5","article-title":"Exosome miRNA-203 promotes M1 macrophage polarization and inhibits prostate cancer tumor progression","volume":"479","author":"Zhang","year":"2023","journal-title":"Mol Cell Biochem"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0609385","article-title":"Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation","volume":"86","author":"Solinas","year":"2009","journal-title":"J Leukoc Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nature07623","article-title":"Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis","volume":"457","author":"Kim","year":"2009","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1215397109","article-title":"Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy","volume":"109","author":"Huang","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2019.01.005","article-title":"Iron oxide nanoparticles: diagnostic, therapeutic and theranostic applications","volume":"138","author":"Dadfar","year":"2019","journal-title":"Adv Drug Delivery Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nature12451","article-title":"lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs","volume":"500","author":"Yang","year":"2013","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nature08782","article-title":"B-cell-derived lymphotoxin promotes castration-resistant prostate cancer","volume":"464","author":"Ammirante","year":"2010","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1221055110","article-title":"Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth","volume":"110","author":"Hirsch","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.4244","article-title":"Safety and survival with GVAX pancreas prime and Listeria monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer","volume":"33","author":"Le","year":"2015","journal-title":"J Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.042671","article-title":"CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization","volume":"284","author":"Roca","year":"2009","journal-title":"J Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cas.12314","article-title":"Clinical significance of macrophage heterogeneity in human Malignant tumors","volume":"105","author":"Komohara","year":"2014","journal-title":"Cancer Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","article-title":"How chemokines organize the tumour microenvironment","volume":"24","author":"Mempel","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1126\/science.adn9083","article-title":"In vivo dendritic cell reprogramming for cancer immunotherapy","volume":"386","author":"Ascic","year":"2024","journal-title":"Science"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216894","article-title":"Unraveling the tumor microenvironment: insights into cancer metastasis and therapeutic strategies","volume":"591","author":"El-Tanani","year":"2024","journal-title":"Cancer Lett"},{"key":"B27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","article-title":"Tumor microenvironment complexity and therapeutic implications at a glance","volume":"18","author":"Baghban","year":"2020","journal-title":"Cell Commun Signal"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16132438","article-title":"Decoding the intricate landscape of pancreatic cancer: insights into tumor biology, microenvironment, and therapeutic interventions","volume":"16","author":"Argentiero","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1517312","article-title":"Integrative multi-omics analysis reveals a novel subtype of hepatocellular carcinoma with biological and clinical relevance","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/life15020228","article-title":"Notch and Hedgehog signaling unveiled: crosstalk, roles, and breakthroughs in cancer stem cell research","volume":"15","author":"Iluta","year":"2025","journal-title":"Life (Basel)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12539","article-title":"Immunologic tumor microenvironment modulators for turning cold tumors hot","volume":"44","author":"Khosravi","year":"2024","journal-title":"Cancer Commun (Lond)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1177\/17588359231186027","article-title":"The introduction of LAG-3 checkpoint blockade in melanoma: immunotherapy landscape beyond PD-1 and CTLA-4 inhibition","volume":"15","author":"Kreidieh","year":"2023","journal-title":"Ther Adv Med Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211631","article-title":"CCR2\/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma","volume":"219","author":"Wang","year":"2022","journal-title":"J Exp Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12416","article-title":"Tumor microenvironment signaling and therapeutics in cancer progression","volume":"43","author":"Goenka","year":"2023","journal-title":"Cancer Commun (Lond)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12607","article-title":"Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD-1 therapy in hepatocellular carcinoma","volume":"44","author":"Cai","year":"2024","journal-title":"Cancer Commun (Lond)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216267","article-title":"Lipid metabolism reprogramming of CD8(+) T cell and therapeutic implications in cancer","volume":"567","author":"Wang","year":"2023","journal-title":"Cancer Lett"},{"key":"B37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-024-01600-2","article-title":"Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution","volume":"17","author":"Zhang","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00706-6","article-title":"Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment","volume":"24","author":"Polak","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.stem.2024.04.018","article-title":"Breast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cells","volume":"31","author":"Maulana","year":"2024","journal-title":"Cell Stem Cell"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J Cell Physiol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/s1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00541-3","article-title":"Macrophages and the maintenance of homeostasis","volume":"18","author":"Mosser","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adg1487","article-title":"Lung tumor-infiltrating T(reg) have divergent transcriptional profiles and function linked to checkpoint blockade response","volume":"8","author":"Dykema","year":"2023","journal-title":"Sci Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.12226","article-title":"Tumor-associated macrophages: a sentinel of innate immune system in tumor microenvironment gone haywire","volume":"48","author":"Malik","year":"2024","journal-title":"Cell Biol Int"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70095","article-title":"Exosomes: a double-edged sword in cancer immunotherapy","volume":"6","author":"Chen","year":"2025","journal-title":"MedComm (2020)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13045-024-01535-8","article-title":"Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy","volume":"17","author":"Lu","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.17305\/bb.2023.9675","article-title":"CAR-macrophage versus CAR-T for solid tumors: the race between a rising star and a superstar","volume":"24","author":"Chen","year":"2024","journal-title":"Biomol BioMed"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24664","article-title":"Diagnosis and management of neuroendocrine prostate cancer","volume":"84","author":"de Kouchkovsky","year":"2024","journal-title":"Prostate"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009368","article-title":"Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy","volume":"12","author":"Al-Janabi","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-3350","article-title":"Reversal of lactate and PD-1-mediated macrophage immunosuppression controls growth of PTEN\/p53-deficient prostate cancer","volume":"29","author":"Chaudagar","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1101\/2023.05.23.540590","article-title":"Suppression of tumor cell lactate-generating signaling pathways eradicates murine PTEN\/p53-deficient aggressive-variant prostate cancer via macrophage phagocytosis","author":"Chaudagar","year":"2023","journal-title":"bioRxiv"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"key":"B54","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12951-024-02496-3","article-title":"Irradiated microparticles suppress prostate cancer by tumor microenvironment reprogramming and ferroptosis","volume":"22","author":"Deng","year":"2024","journal-title":"J Nanobiotechnology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1172\/JCI158352","article-title":"UBC9 deficiency enhances immunostimulatory macrophage activation and subsequent antitumor T cell response in prostate cancer","volume":"133","author":"Xiao","year":"2023","journal-title":"J Clin Invest"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-20-0855","article-title":"Immunomodulatory activity of a colony-stimulating factor-1 receptor inhibitor in patients with advanced refractory breast or prostate cancer: A phase I study","volume":"26","author":"Autio","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003005","article-title":"GB1275, a first-in-class CD11b modulator: Rationale for immunotherapeutic combinations in solid tumors","volume":"9","author":"DeNardo","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-22-3350","article-title":"Reversal of lactate and PD-1\u2013mediated macrophage immunosuppression controls growth of PTEN\/p53-deficient prostate cancer","volume":"29","author":"Chaudagar","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00247","article-title":"Multifaceted roles for macrophages in prostate cancer skeletal metastasis","volume":"9","author":"Lo","year":"2018","journal-title":"Front Endocrinol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2005.08.021","article-title":"Granulocyte-macrophage colony-stimulating factor-transduced allogeneic cancer cellular immunotherapy: The GVAX\u00ae vaccine for prostate cancer","volume":"24","author":"Simons","year":"2006","journal-title":"Urologic Oncol Semin Original Investigations"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1560998","article-title":"Intercellular communication between FAP+ fibroblasts and SPP1+ macrophages in prostate cancer via multi-omics","volume":"16","author":"Wu","year":"2025","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00262-024-03633-5","article-title":"Identification macrophage signatures in prostate cancer by single-cell sequencing and machine learning","volume":"73","author":"Kang","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08290-3","article-title":"Evolution of myeloid-mediated immunotherapy resistance in prostate cancer","volume":"637","author":"Lyu","year":"2025","journal-title":"Nature"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.Mcr-24-0791","article-title":"Single-cell and spatial transcriptomics reveal a tumor-associated macrophage subpopulation that mediates prostate cancer progression and metastasis","volume":"23","author":"Mei","year":"2025","journal-title":"Mol Cancer Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"9949","DOI":"10.1038\/s41467-024-54364-1","article-title":"Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer","volume":"15","author":"Kiviaho","year":"2024","journal-title":"Nat Commun"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911943","article-title":"Lactate-lactylation hands between metabolic reprogramming and immunosuppression","volume":"23","author":"Chen","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2021.0306","article-title":"The Wnt\/\u03b2-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma","volume":"18","author":"Wang","year":"2021","journal-title":"Cancer Biol Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.tig.2022.10.004","article-title":"Genetic and epigenetic defects of the RNA modification machinery in cancer","volume":"39","author":"Orsolic","year":"2023","journal-title":"Trends Genet"},{"key":"B69","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41419-023-06007-4","article-title":"Exosomal PGAM1 promotes prostate cancer angiogenesis and metastasis by interacting with ACTG1","volume":"14","author":"Luo","year":"2023","journal-title":"Cell Death Dis"},{"key":"B70","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13046-023-02720-2","article-title":"Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer","volume":"42","author":"Wang","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-008799","article-title":"Combining toll-like receptor agonists with immune checkpoint blockade affects antitumor vaccine efficacy","volume":"12","author":"Jeon","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010767","article-title":"Targeted release of a bispecific fusion protein SIRPalpha\/Siglec-10 by oncolytic adenovirus reinvigorates tumor-associated macrophages to improve therapeutic outcomes in solid tumors","volume":"13","author":"Zhang","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202305724","article-title":"Integration analysis of single-cell multi-omics reveals prostate cancer heterogeneity","volume":"11","author":"Bian","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B74","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13046-024-02962-8","article-title":"Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1\/STAT4 pathway","volume":"43","author":"Cheng","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.03.018","article-title":"A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer","author":"Liu","year":"2025","journal-title":"Cell"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01678-9","article-title":"Decoding the tumor microenvironment with spatial technologies","volume":"24","author":"Walsh","year":"2023","journal-title":"Nat Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216954","article-title":"Diverse landscape of genetically engineered mouse models: Genomic and molecular insights into prostate cancer","volume":"593","author":"Kaushal","year":"2024","journal-title":"Cancer Lett"},{"key":"B78","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/JU.0000000000003492","article-title":"Early detection of prostate cancer: AUA\/SUO guideline part II: Considerations for a prostate biopsy","volume":"210","author":"Wei","year":"2023","journal-title":"J Urol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1784198\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:25:01Z","timestamp":1777868701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1784198\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":78,"alternative-id":["10.3389\/fonc.2026.1784198"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1784198","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"article-number":"1784198"}}